Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Oslo Bors  >  Idex Biometrics ASA    IDEX   NO0003070609

IDEX BIOMETRICS ASA

(IDEX)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M NOK Estimates in M NOK
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 38,6 17,5 3,59 52,4 340 670
EBITDA -196 -242 -237 -231 -113 19,0
Operating profit (EBIT) -203 -249 -244 -239 -122 9,18
Pre-Tax Profit (EBT) -202 -251 -246 -238 -122 9,42
Net income -203 -255 -246 -238 -122 9,42
P/E ratio -18,4x -11,0x -6,74x -3,85x -7,51x 78,9x
EPS ( NOK ) -0,38 -0,47 -0,45 -0,41 -0,21 0,02
Dividend per Share ( NOK ) - - - - - -
Yield - - - - - -
Reference price ( NOK ) 6,990 5,160 3,035 1,578 1,578 1,578
Announcement Date 02/23/2017
05:37pm
02/22/2018
06:11am
02/27/2019
06:02am
- - -
Finances - Leverage
Actuals in M NOK Estimates in M NOK
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 533 302 83,7 95,5 0,90 38,7
Operating income (EBITDA) -196 -242 -237 -231 -113 19,0
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 1,34 7,15 8,99 1,02 1,02 2,68
Free Cash Flow (FCF) -232 -242 -223 -200 -100 38,0
Book Value Per Share (BVPS) ( NOK ) 1,05 0,62 0,23 0,23 0,07 0,14
Cash Flow per Share (  ) - - - - - -
Announcement Date 02/23/2017
05:37pm
02/22/2018
06:11am
02/27/2019
06:02am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 944 M NOK -
Entreprise Value (EV) 848 M NOK 943 M NOK
Valuation 2019e 2020e
P/E ratio (Price / EPS) -3,85x -7,51x
Capitalization / Revenue 18,0x 2,77x
EV / Revenue 16,2x 2,49x
EV / EBITDA -3,66x -7,48x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 6,86x 22,5x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) -456% -35,9%
Operating Leverage (Delta EBIT / Delta Sales) 0,00x 0,09x
Net Margin (Net Profit / Revenue) -455% -35,8%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -192% -152%
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   1,95% 0,30%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend